View Post

Hot flashes caused by cancer therapy can be prevented, treated

In In The News by Barbara Jacoby0 Comments

By: Carolyn Crist From: reuters.com Cancer patients with hot flashes related to hormone therapy should know that these uncomfortable symptoms can be managed, according to a recently published resource for patients. “The goal of any therapy is to help patients feel better, and we don’t want them to needlessly suffer and think there are no treatments available,” said Dr. Arjun …

View Post

Experts report new guidelines for clinical trial design in patients with brain metastases

In In The News by Barbara Jacoby0 Comments

Source: ucdenver.edu From: news-medical.net Clinical trials of new anti-cancer therapies have often excluded patients whose disease has spread to the brain or central nervous system (CNS) or, if such patients were allowed on trial, trials have often failed to clearly capture information on the drug’s effect in the brain. Today new guidelines from an international, multidisciplinary group published in the …

View Post

New biomarkers predict outcome of cancer immunotherapy

In In The News by Barbara Jacoby0 Comments

Source: University of Zurich From: sciencedaily.com Nowadays, melanoma and lung cancer can be combatted effectively through immunotherapy, which makes targeted use of the immune system’s normal function of regularly examining the body’s tissue for pathogens and damages. Specific inhibitors are used to activate immune cells in a way that makes them identify cancer cells as foreign bodies and eliminate them. …

View Post

Memorial Plastic Surgery Joins Komen Houston Race for the Cure

In In The News by Barbara Jacoby0 Comments

On January 27, 2018, Dr. Patrick Hsu and Dr. Kendall Roehl, together with Memorial Plastic Surgery’s staff and patients, are encouraging everyone to join them for the Susan G. Komen Race for the Cure® at the Sam Houston Park in Downtown Houston. Held in various cities in the United States and around the world, the Susan G. Komen Race for …

View Post

Is it time to say goodbye to ClinicalTrials.Gov?

In In The News by Barbara Jacoby0 Comments

By: Zikria Syed From: medcitynews.com It is an exciting time in the pharmaceutical industry. According to industry organization PHRMA, there are currently more than 7,000 new medicines under development with many being first in class treatments. Digital technology combined with medicine, gene therapy and personalized medicine are driving a lot of this. However, to bring these treatments to market, clinical trials …

View Post

First treatment approved for breast cancer with BRCA genetic mutation

In In The News by Barbara Jacoby0 Comments

By: Laurie McGinley From: washingtonpost.com The Food and Drug Administration on Friday cleared the first treatment for patients with advanced breast cancer caused by BRCA mutations, which are genetic defects that raise the risk of malignancies. The drug, called Lynparza, already is approved for certain patients with advanced ovarian cancer associated with the same mutations. Richard Pazdur, director of the …